tiprankstipranks
Trending News
More News >
AptarGroup (ATR)
NYSE:ATR
US Market
Advertisement

AptarGroup (ATR) Earnings Dates, Call Summary & Reports

Compare
155 Followers

Earnings Data

Report Date
Oct 30, 2025
After Close (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
1.57
Last Year’s EPS
1.49
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 31, 2025|
% Change Since: -10.43%|
Earnings Call Sentiment|Positive
The earnings call presented a mix of strong financial performance and strategic achievements in key segments, despite challenges in certain areas like Consumer Healthcare and Prestige Beauty. Legal expenses and naloxone sales normalization pose potential headwinds. Overall, the sentiment is slightly positive, with significant achievements in Pharma and Closures segments outweighing the challenges.
Company Guidance -
Q3 2025
During Aptar's 2025 Q2 earnings call, the company reported an adjusted earnings per share of $1.66, marking an 18% increase over the previous year's quarter, exceeding the high end of their guidance range. Core sales rose, particularly driven by the Pharma and Closures segments. The Pharma segment saw strong demand in prescription, injectables, and active materials, with core sales increases of 8%, 9%, and 11%, respectively. The Closures segment benefited from a robust innovation pipeline. While the Consumer Healthcare division faced challenges due to softer demand in Europe, the company highlighted the acquisition of Mod3 Pharma, enhancing capabilities in clinical trial manufacturing. The company also noted that its Beauty segment experienced a 4% decrease in fragrance, skincare, and cosmetics sales, mainly due to trade uncertainties affecting Prestige beauty. Aptar plans to maintain cost discipline, with SG&A expenses decreasing as a percentage of sales. Looking ahead, the company anticipates third-quarter adjusted EPS to range from $1.53 to $1.61.
Strong Earnings Growth
Adjusted earnings per share increased by 18% over the prior year quarter, exceeding the high end of guidance range with $1.66 per share.
Robust Pharma Segment Performance
Pharma segment showed strong core sales growth with Prescription increasing by 8%, Injectables by 9%, and Active Materials Science Solutions by 11%.
Successful Mod3 Pharma Acquisition
Acquisition of Mod3 Pharma's clinical trial manufacturing capabilities expands Aptar Pharma services and strengthens its position in early-stage development.
Recognition and Awards
Aptar named one of Time Magazine's World's Most Sustainable Companies for the second consecutive year and added to CDP's Supplier Engagement Assessment A List.
Closure Segment Growth
Core sales in the Closures segment increased by 7%, driven by strong demand in food and beverage markets.
Improved EBITDA Margin
Consolidated adjusted EBITDA margins expanded by 140 basis points to 22.6% compared to 21.2% in the prior year.

AptarGroup (ATR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ATR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 30, 2025
2025 (Q3)
1.57 / -
1.49
Jul 31, 2025
2025 (Q2)
1.59 / 1.66
1.3721.17% (+0.29)
May 01, 2025
2025 (Q1)
1.16 / 1.20
1.26-4.76% (-0.06)
Feb 06, 2025
2024 (Q4)
1.26 / 1.52
1.2125.62% (+0.31)
Oct 24, 2024
2024 (Q3)
1.42 / 1.49
1.397.19% (+0.10)
Jul 25, 2024
2024 (Q2)
1.36 / 1.37
1.2311.38% (+0.14)
Apr 25, 2024
2024 (Q1)
1.15 / 1.26
0.9532.63% (+0.31)
Feb 08, 2024
2023 (Q4)
1.12 / 1.21
0.9231.52% (+0.29)
Oct 25, 2023
2023 (Q3)
1.27 / 1.39
0.9546.32% (+0.44)
Jul 27, 2023
2023 (Q2)
1.14 / 1.23
0.9628.13% (+0.27)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ATR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 31, 2025
$157.14$141.35-10.05%
May 01, 2025
$147.87$151.58+2.51%
Feb 06, 2025
$155.55$142.35-8.49%
Oct 24, 2024
$165.12$167.46+1.42%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does AptarGroup (ATR) report earnings?
AptarGroup (ATR) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).
    What is AptarGroup (ATR) earnings time?
    AptarGroup (ATR) earnings time is at Oct 30, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ATR EPS forecast?
          ATR EPS forecast for the fiscal quarter 2025 (Q3) is 1.57.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis